Oerlikon launches MetcoMed brand with metal powders for medical Additive Manufacturing applications
May 13, 2025
Oerlikon Metco, headquartered in Winterthur, Switzerland, has launched its new MetcoMed brand with the release of two materials tailored for the Additive Manufacturing of medical components and implants. The new metal powders, MetcoMed Ti64 G23-C, a titanium alloy, and MetcoMed CoCrMo F75-A, a cobalt-chromium alloy, are now available through the company’s distribution network.
MetcoMed Ti64 G23-C
Building on the established and industry-approved alloy for Additive Manufacturing, Oerlikon’s MetcoMed Ti64 G23-C is said to provide high load-bearing capacity, good ductility, excellent biocompatibility, and good corrosion resistance.
The material reportedly offers a tensile strength of over 1000 MPa at 10% elongation. It has been optimised for Laser Beam Powder Bed Fusion Additive Manufacturing technology and can function as a direct drop-in solution for most machine brands.
MetcoMed CoCrMo F75-A
Cobalt-chromium alloys are widely used for various orthopaedic and dental implants, with CoCrMo one of the most used alloys for tooth implants and total hip replacement due to its superior corrosion qualities, antibacterial properties, improved cell adhesion, and potential for reducing inflammation markers.
Oerlikon has developed and launched a CoCrMo material specifically for PBF-LB Additive Manufacturing, noting the material’s high strength, ductility, and biocompatibility. MetcoMed CoCrMo F75-A provides a reported tensile strength of 1050 MPa and 35% elongation despite its low carbon content (desirable for an implant material). The powder exhibits a particle size distribution that enables its use on most PBF-LB AM platforms.
